Generic Glucophage (Metaformin Hydrochloride Tablets) is used for the treatment of Type 2 Diabetes. Generic Glucophage, used correctly, can control the blood sugar levels in the body.

Generic Glucophage was developed by a French Pharmacist, Jan Aron in 1958. Instead of making the human body produce more insulin, Generic Glucophage helps the body respond to its own insulin. With the help of Dr. Jean Sterne, who determined that the medication could be given orally in varying amounts based on the persons needs, Glucophage was approved in France in 1960. In 1962 Glucophage was distributed worldwide with the exception of the United States.

Since this medication can be given in different amounts depending upon the persons needs, the idea is to find the lowest possible amount required to maintain a normal blood sugar level. For further information concerning this product, see the Metormin Information Page.

Directions

Start with one tablet of 500mg every morning. Continue to test blood sugar levels to determine if more medication is necessary. If more is needed, increase by taking another 500mg tablet at dinner. The usual amount of medication that is used is 1500mg per day.

NEVER EXCEED 2500mg PER DAY AND ALWAYS TAKE WITH FOOD.

Other Brand Names

In some countries Generic Glucophage is also known as:
Metformin
Benofomin (Indonesia)
Dextin (South-Africa)
Diabetmin (Malaysia)
Diabex (Australia; Indonesia)
Diaformin (Australia; Hong-Kong; Taiwan)
Diamin (Malaysia)
Diaphage (India)
Diformin (Finland)
Diformin Retard (Finland)
Fornidd (Philippines)
Geamet (Benin; Burkina-Faso; Ethiopia; Gambia; Ghana; Guinea; Ivory-Coast; Kenya; Liberia; Malawi; Mali; Mauritania; Mauritius; Morocco; Niger; Nigeria; Senegal; Seychelles; Sierra-Leone; Sudan; Tanzania; Tunia; Uganda; Zambia; Zimbabwe)
Glucofago (Peru)
Glucomet (New-Zealand; Thailand)
Glucomine (Taiwan)
Glucoform (Philippines)
Gluconil (Korea)
Glucophage 850 (Thailand)
Glucophage Forte (Czech-Republic; Mexico; Netherlands; Philippines; South-Africa)
Glucophage-Mite (Germany)
Glucophage Retard (Germany; Israel)
Gluformin (Thailand)
Glupermin (Korea)
Glyciphage (India)
Metforal (Bahrain; Cyprus; Egypt; Iran; Iraq; Italy; Jordan; Kuwait; Lebanon; Libya; Oman; Qatar; Republic-Of-Yemen; Saudi-Arabia; Syria; United-Arab-Emirates)
Metomin (New-Zealand)
Miformin (Thailand)
Orabet (Bahrain; Cyprus; Denmark; Egypt; Iran; Iraq; Jordan; Kuwait; Lebanon; Libya; Oman; Qatar; Republic-Of-Yemen; Saudi-Arabia; Syria; United-Arab-Emirates)
Siamformet (Thailand)